Tsapis N - Search Results

1

How should we plan the future of nanomedicine for cancer diagnosis and therapy?

Alhareth K, Sancey L, Tsapis N, Mignet N. Alhareth K, et al. Among authors: tsapis n. Int J Pharm. 2017 Nov 5;532(2):657-659. doi: 10.1016/j.ijpharm.2017.05.037. Epub 2017 May 19. Int J Pharm. 2017. PMID: 28533174 No abstract available.

2

Encapsulation of dexamethasone into biodegradable polymeric nanoparticles.

Gómez-Gaete C, Tsapis N, Besnard M, Bochot A, Fattal E. Gómez-Gaete C, et al. Among authors: tsapis n. Int J Pharm. 2007 Mar 1;331(2):153-9. doi: 10.1016/j.ijpharm.2006.11.028. Epub 2006 Nov 12. Int J Pharm. 2007. PMID: 17157461

3

Removal of ciprofloxacin in simulated digestive media by activated charcoal entrapped within zinc-pectinate beads.

Khoder M, Tsapis N, Huguet H, Besnard M, Gueutin C, Fattal E. Khoder M, et al. Among authors: tsapis n. Int J Pharm. 2009 Sep 11;379(2):251-9. doi: 10.1016/j.ijpharm.2009.05.035. Epub 2009 May 23. Int J Pharm. 2009. PMID: 19467304

4

Aerosolized liposomal amphotericin B: prediction of lung deposition, in vitro uptake and cytotoxicity.

Fauvel M, Farrugia C, Tsapis N, Gueutin C, Cabaret O, Bories C, Bretagne S, Barratt G. Fauvel M, et al. Among authors: tsapis n. Int J Pharm. 2012 Oct 15;436(1-2):106-10. doi: 10.1016/j.ijpharm.2012.07.012. Epub 2012 Jul 17. Int J Pharm. 2012. PMID: 22814222

5

Targeted nanotheranostics for personalized cancer therapy.

Diou O, Tsapis N, Fattal E. Diou O, et al. Among authors: tsapis n. Expert Opin Drug Deliv. 2012 Dec;9(12):1475-87. doi: 10.1517/17425247.2012.736486. Epub 2012 Oct 23. Expert Opin Drug Deliv. 2012. PMID: 23092183 Review.

6

Formulation of pyrazinamide-loaded large porous particles for the pulmonary route: avoiding crystal growth using excipients.

Pham DD, Fattal E, Ghermani N, Guiblin N, Tsapis N. Pham DD, et al. Among authors: tsapis n. Int J Pharm. 2013 Oct 1;454(2):668-77. doi: 10.1016/j.ijpharm.2013.04.016. Epub 2013 Apr 17. Int J Pharm. 2013. PMID: 23603099

7

Toxicity of surface-modified PLGA nanoparticles toward lung alveolar epithelial cells.

Grabowski N, Hillaireau H, Vergnaud J, Santiago LA, Kerdine-Romer S, Pallardy M, Tsapis N, Fattal E. Grabowski N, et al. Among authors: tsapis n. Int J Pharm. 2013 Oct 1;454(2):686-94. doi: 10.1016/j.ijpharm.2013.05.025. Epub 2013 Jun 6. Int J Pharm. 2013. PMID: 23747506

8

Influence of polymer end-chemistry on the morphology of perfluorohexane polymeric microcapsules intended as ultrasound contrast agents.

Mousnier L, Huang N, Morvan E, Fattal E, Tsapis N. Mousnier L, et al. Among authors: tsapis n. Int J Pharm. 2014 Aug 25;471(1-2):10-7. doi: 10.1016/j.ijpharm.2014.05.012. Epub 2014 May 13. Int J Pharm. 2014. PMID: 24836666

9

Surface coating mediates the toxicity of polymeric nanoparticles towards human-like macrophages.

Grabowski N, Hillaireau H, Vergnaud J, Tsapis N, Pallardy M, Kerdine-Römer S, Fattal E. Grabowski N, et al. Among authors: tsapis n. Int J Pharm. 2015 Mar 30;482(1-2):75-83. doi: 10.1016/j.ijpharm.2014.11.042. Epub 2014 Nov 18. Int J Pharm. 2015. PMID: 25448553

10

Pulmonary drug delivery systems for tuberculosis treatment.

Pham DD, Fattal E, Tsapis N. Pham DD, et al. Among authors: tsapis n. Int J Pharm. 2015 Jan 30;478(2):517-29. doi: 10.1016/j.ijpharm.2014.12.009. Epub 2014 Dec 10. Int J Pharm. 2015. PMID: 25499020 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

122 results

Search Page